Noninvasive assessment of systolic pulmonary artery pressure in systemic lupus erythematosus: Retrospective analysis of 93 patients

Clinical and Experimental Rheumatology

Volumn 28, Issue 6, 2010, Pages 836-841

  Fois E ^a   Le Guern, V ^a   Dupuy, A ^b   Humbert, M ^c   Mouthon, L ^a   Guillevin, L ^a  

^a University Paris Descartes ^*  (France)

^b SAINT LOUIS HOSPITAL   (France)

^c HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

Prognosis; Pulmonary arterial hypertension; Pulmonary hypertension; Systemic lupus erythematosus

Indexed keywords

ANTICOAGULANT AGENT; BETA2 GLYCOPROTEIN 1 ANTIBODY; BOSENTAN; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; LUPUS ANTICOAGULANT; SILDENAFIL; SM ANTIBODY;

ADULT; AFRICAN AMERICAN; AFRICAN CARIBBEAN; AGED; ANTIBODY BLOOD LEVEL; ANTIPHOSPHOLIPID ANTIBODY SYNDROME; ARTERY THROMBOSIS; ARTICLE; BRAIN VASCULITIS; CAUCASIAN; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE DURATION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; HEART LEFT VENTRICLE FAILURE; HUMAN; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LUNG ARTERY PRESSURE; LUNG DISEASE; LUNG EDEMA; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; MESENTERIC VEIN THROMBOSIS; MONONEUROPATHY MULTIPLEX; MYOCARDITIS; NORTH AFRICA; OUTCOME ASSESSMENT; PERICARDITIS; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; POPLITEAL ARTERY THROMBOSIS; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETINA VASCULITIS; RETROSPECTIVE STUDY; SEIZURE; SPLEEN VEIN THROMBOSIS; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOTIC THROMBOCYTOPENIC PURPURA; TRANSIENT ISCHEMIC ATTACK; VALVULAR HEART DISEASE; VEIN THROMBOSIS; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; ECHOGRAPHY; HEART CATHETERIZATION; HOSPITALIZATION; KAPLAN MEIER METHOD; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY ARTERY;

ADULT; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART CATHETERIZATION; HUMANS; HYPERTENSION, PULMONARY; KAPLAN-MEIER ESTIMATE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PULMONARY ARTERY; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 79952647628     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. . GALIE N, HOEPER MM, HUMBERT M et al:. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009; 34: 1219-63.
2. Galie N, Hoeper MM, Humbert M et al.: Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30: 2493-537.
3. Humbert M, Sitbon O, Chaouat A et al:. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006; 173: 1023-30.
4. Simonneau G, Galie N, Rubin Lj et al:. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43 (Suppl. S) 5S-12S.
5. . HACHULLA E, GRESSIN V, GUlLLEVIN L et al.: Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005; 52: 3792-800.
6. MUKERJEE D, ST GEORGE D, COLEIRO B et al.: Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003; 62: 1088-93.
7. STEEN VD, MEDSGER TA: Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007; 66: 940-4.
8. HACHULLA E, CARPENTIER P, GRESSIN V et al.: Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinerAIR-Sclerodermie study. Rheumatology (Oxford) 2009; 48: 304-8.
9. HOCHBERG MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
10. IPPOLITO A, PETRI M: An update on mortality in systemic lupus erythematosus. Clin Exp Rheumatol 2008; 26 (Suppl. 51): S72-9.
11. ASHERSON RA: Pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 1990; 17: 414-5.
12. CHUNG SM, LEECK, LEEEY: Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension. Clin Rheumatol 2006; 25: 866-72.
13. LI EK, TAM LS: Pulmonary hypertension in systemic lupus erythematosus: clinical association and survival in 18 patients. J Rheumatol 1999; 26: 1923-9.
14. Shen JY, Chen SL, Wu YX et al.: Pulmonary hypertension in systemic lupus erythematosus. Rheumatol Im 1999; 18: 147-51.
15. SIMONSON JS, SCHILLER NB, PETRI M, HELLMANN DB: Pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 1989; 16: 918-25.
16. WINSLOW TM, OSSIPOV MA, FAZIO GP, SIMONSON JS, REDBERG RF, SCHILLER NB: Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus. Am Heart J 1995; 129: 510-5.
17. PAN TL, THUMBOO J, BOEY ML: Primary and secondary pulmonary hypertension in systemic lupus erythematosus. Lupus 2000; 9: 338-42.
18. JOHNSON SR, GLADMAN DD, UROWITZ MB, IBANEZ D, GRANTON JT: Pulmonary hypertension in systemic lupus. Lupus 2004; 13: 506-9.
19. SANCHEZ O, SITBON O, JAIS X: Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension. Chest 2006; 13: 182-9.
20. JAIS X, LAUNAY D, YAICIA et al: Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. Arthritis Rheum 2008; 58: 521-31.
21. DENTON CP, CAlLES JB, PHILLIPS GD, WELLS AU, BLACK CM, BOIS RM: Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. Br J Rheumatol 1997; 36: 239-43.